End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
790,000 KRW | -0.13% | +1.80% | +3.95% |
08:05am | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
07:19am | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.